Simulations Plus
Open
$14.12
Prev. Close
$14.09
High
$14.20
Low
$14.12
Market Snapshot
$281.85M
-4.5
0.41
$74.44M
213
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
emptyResult
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Recently from Cashu
Rosen Law Probes Simulations Plus Over Q3 Sales and Preliminary Revenue Disclosures
Investigation Questions Simulations Plus’ Sales Disclosures and Demand Outlook Rosen Law Firm is investigating potential securities claims accusing Simulations Plus Inc. of issuing materially misleadi…
Rosen Law Opens Class-Action Probe into Simulations Plus Over Alleged Misleading Q3 2025 Disclosures
Legal Probe Targets Simulations Plus’ Disclosures Rosen Law Firm is investigating potential securities claims against Simulations Plus, Inc., alleging the company issued materially misleading business…
Rosen Law Investigates Simulations Plus Over Alleged Misleading Sales Disclosures
Legal Inquiry Opens Into Simulations Plus' Sales Disclosures Rosen Law Firm is opening an investigation into Simulations Plus Inc. over allegations that the company issues materially misleading busine…
Simulations Plus Faces Legal Investigation Over Alleged Misleading Information Impacting Shareholders
### Legal Scrutiny Intensifies for Simulations Plus Amid Allegations of Misleading Information Simulations Plus, Inc. faces a significant legal challenge as the Rosen Law Firm initiates an investigati…